GOODBODY HEALTH LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -90.00% |
|
0.00% | -99.67% |
Valuation
| Fiscal Period: December | 2020 | 2021 |
|---|---|---|
| Capitalization 1 | 12.17 | 13.76 |
| Enterprise Value (EV) 1 | 10.8 | 8.027 |
| P/E ratio | -1.4 x | -5.64 x |
| Yield | - | - |
| Capitalization / Revenue | 6.1 x | 0.81 x |
| EV / Revenue | 5.41 x | 0.47 x |
| EV / EBITDA | -2.28 x | -35 x |
| EV / FCF | -8,406,247 x | 3,439,916 x |
| FCF Yield | -0% | 0% |
| Price to Book | 1.94 x | 1.95 x |
| Nbr of stocks (in thousands) | 30,259 | 36,496 |
| Reference price 2 | 0.4022 | 0.3770 |
| Announcement Date | 4/30/21 | 5/2/22 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Net sales 1 | 0.26 | 1.449 | 1.994 | 17.06 |
| EBITDA 1 | -1.715 | -3.381 | -4.726 | -0.2291 |
| EBIT 1 | -1.829 | -3.553 | -5.042 | -1.082 |
| Operating Margin | -703.46% | -245.2% | -252.85% | -6.35% |
| Earnings before Tax (EBT) 1 | -1.859 | -3.797 | -4.787 | -2.247 |
| Net income 1 | -1.859 | -3.797 | -4.659 | -2.314 |
| Net margin | -715% | -262.04% | -233.61% | -13.57% |
| EPS 2 | -0.0520 | -0.0725 | -0.2868 | -0.0669 |
| Free Cash Flow | - | -1.976 | -1.285 | 2.333 |
| FCF margin | - | -136.4% | -64.41% | 13.68% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 5/14/19 | 6/3/20 | 4/30/21 | 5/2/22 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q3 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | -1.266 |
| Net margin | - |
| EPS | - |
| Dividend per Share | - |
| Announcement Date | 11/10/22 |
1GBP in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | 3.74 | 1.37 | 1.37 | 5.73 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | -1.98 | -1.28 | 2.33 |
| ROE (net income / shareholders' equity) | - | -89.7% | -95.2% | -34.7% |
| ROA (Net income/ Total Assets) | - | -45.3% | -49.4% | -7.1% |
| Assets 1 | - | 8.378 | 9.432 | 32.59 |
| Book Value Per Share 2 | 0.0100 | 0.0100 | 0.2100 | 0.1900 |
| Cash Flow per Share 2 | 0.0100 | 0 | 0.0600 | 0.1700 |
| Capex 1 | 0.18 | 0.53 | 0.21 | 0.24 |
| Capex / Sales | 69.62% | 36.23% | 10.58% | 1.42% |
| Announcement Date | 5/14/19 | 6/3/20 | 4/30/21 | 5/2/22 |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -99.67% | 36 | |
| +26.93% | 5.6B | |
| -33.55% | 3.53B | |
| -3.74% | 3.03B | |
| -26.09% | 2.58B | |
| -10.93% | 2.31B | |
| +41.50% | 1.86B | |
| +41.84% | 1.45B | |
| +47.62% | 1.41B | |
| -28.07% | 1.27B |
- Stock Market
- Equities
- GDBYF Stock
- Financials Goodbody Health Limited
